202 related articles for article (PubMed ID: 19549337)
1. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation.
Gill C; Dowling C; O'Neill AJ; Watson RW
Mol Cancer; 2009 Jun; 8():39. PubMed ID: 19549337
[TBL] [Abstract][Full Text] [Related]
2. Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Guicciardi ME; Mott JL; Bronk SF; Kurita S; Fingas CD; Gores GJ
Exp Cell Res; 2011 Jan; 317(1):107-16. PubMed ID: 20951133
[TBL] [Abstract][Full Text] [Related]
3. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
[TBL] [Abstract][Full Text] [Related]
4. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM
Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672
[TBL] [Abstract][Full Text] [Related]
5. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
6. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
[TBL] [Abstract][Full Text] [Related]
7. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
8. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
Gill C; Walsh SE; Morrissey C; Fitzpatrick JM; Watson RW
Prostate; 2007 Nov; 67(15):1641-53. PubMed ID: 17823925
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs.
Finlay D; Vamos M; González-López M; Ardecky RJ; Ganji SR; Yuan H; Su Y; Cooley TR; Hauser CT; Welsh K; Reed JC; Cosford ND; Vuori K
Mol Cancer Ther; 2014 Jan; 13(1):5-15. PubMed ID: 24194568
[TBL] [Abstract][Full Text] [Related]
11. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
[TBL] [Abstract][Full Text] [Related]
12. Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity.
Guicciardi ME; Werneburg NW; Bronk SF; Franke A; Yagita H; Thomas G; Gores GJ
PLoS One; 2014; 9(3):e92124. PubMed ID: 24633224
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins.
Sun H; Lu J; Liu L; Yi H; Qiu S; Yang CY; Deschamps JR; Wang S
J Med Chem; 2010 Sep; 53(17):6361-7. PubMed ID: 20684551
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.
Vallo S; Stege H; Berg M; Michaelis M; Winkelmann R; Rothweiler F; Cinatl J
Oncol Rep; 2020 Apr; 43(4):1331-1337. PubMed ID: 32020226
[TBL] [Abstract][Full Text] [Related]
15. Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2.
Jung YH; Lim EJ; Heo J; Kwon TK; Kim YH
Int J Oncol; 2012 Jun; 40(6):1941-8. PubMed ID: 22426894
[TBL] [Abstract][Full Text] [Related]
16. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.
Kim SH; Bommareddy A; Singh SV
Cancer Prev Res (Phila); 2011 Jun; 4(6):897-906. PubMed ID: 21411500
[TBL] [Abstract][Full Text] [Related]
17. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV
Xiao R; An Y; Ye W; Derakhshan A; Cheng H; Yang X; Allen C; Chen Z; Schmitt NC; Van Waes C
Clin Cancer Res; 2019 Nov; 25(21):6463-6474. PubMed ID: 31266830
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the expression of inhibitors of apoptosis during differentiation of prostate epithelial cells.
Long RM; Morrissey C; Walsh S; Hamilton HJ; Farrell N; O'Neill A; Fitzpatrick JM; Watson WR
BJU Int; 2007 Aug; 100(2):445-9. PubMed ID: 17617147
[TBL] [Abstract][Full Text] [Related]
19. Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.
Spee B; Jonkers MD; Arends B; Rutteman GR; Rothuizen J; Penning LC
Mol Cancer; 2006 Sep; 5():34. PubMed ID: 16953886
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3.
Lanuti P; Bertagnolo V; Pierdomenico L; Bascelli A; Santavenere E; Alinari L; Capitani S; Miscia S; Marchisio M
Cell Res; 2009 Sep; 19(9):1079-89. PubMed ID: 19564891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]